Navigation Links
CoreLab Partners Launches New DXA Imaging Service Offerings
Date:10/15/2010

PRINCETON, N.J., Oct. 15 /PRNewswire/ -- CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm Inc. and Medifacts International in February of this year, has launched a full suite of imaging service solutions and quality assurance processes as it relates to Dual Energy X-Ray Absorptiometry (DXA).

"We are pleased to announce that we have formally launched state-of-the-art imaging solutions to address the numerous indications and therapeutic areas of drug development requiring DXA imaging sciences," said CoreLab Partners' President and Chief Executive Officer, Dr. Mike Woehler. "The addition of DXA services to our growing list of modalities is a natural extension of our broad range of services as CoreLab Partners continues to expand its global reach and reputation for excellence across its cross-section of core lab services under our newly combined entity," added Woehler.  

This important launch correlates with the opening of the American Society of Bone Mineral Research (ASBMR) conference which will take place from October 15-19, 2010 at the Metro Toronto Convention Centre in Toronto, ON. Please visit CoreLab Partners at booth number #1507 to learn more about this exciting addition to their global suite of imaging sciences solutions and cardiac safety services.About CoreLab Partners, IncCoreLab Partners, with offices in North America, Europe and Asia, provides complete medical image assessment services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with full-time, board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. CoreLab Partners also provides solutions for the collection, analysis and management of cardiac safety and efficacy information during drug development. Driven by best-in-class science, technology, and service quality, CoreLabs is a global leader providing ECG, TQT, Holter, Ambulatory Blood Pressure Monitoring, Spirometry, Glucometry, and Pulse Wave Analysis. Contact: Kevin D. DuffyVice President, Global Business DevelopmentEmail: kduffy@corelabpartners.comPhone: 609-936-2600This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CoreLab Partners, Inc
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CoreLab Partners Completes First TQT Study in Japan
2. STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment
3. UBC, Max Planck formalize partnership among worlds top quantum physicists
4. ReGear Life Sciences Partners with Life Care Centers of America
5. Signal Genetics Announces Partnership with Array BioPharma to Advance a Multiple Myeloma Program Backed by Companion Diagnostics
6. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
7. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
8. Pennsylvania Partnerships Address Statewide Nursing Shortage
9. DSM Biomedical Announces Continued Partnership with Spinelab
10. NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership
11. Roche Diabetes Care and ICW Announce Technology Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... San Diego, CA (PRWEB) , ... ... ... BioInformatics (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform ... eliminating all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)... INDIANAPOLIS , Oct. 11, 2017  VMS BioMarketing, a ... of a nationwide oncology Clinical Nurse Educator (CNE) network, which ... growing need for communication among health care professionals to enhance ... physicians, nurses, office staff, and other health care professionals to ... for breast cancer. ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
Breaking Biology News(10 mins):